GENE ONLINE|News &
Opinion
Blog

Go Prime
These Two Companies are Helping Push Denmark to the Forefront of Biotech
2022-04-21
Bio-Europe Spring: 2022 Europe Ophthalmic Medication Market Skyrockets
2022-04-20
Compensating for OxyContin: The Harm from Pharma
2022-04-12
Insider: Groundbreaking Malaria Vaccine Reinvigorates the Fight against Disease
2022-03-30
Market Insight on FDA-approvals: Rise of First-in-class and Regenerative Innovations
2022-03-17
From Forbidden Drugs to Psychotropic Cures: A “Psychedelic Boom” Breaks New Ground in Treating Mental Illnesses
2022-03-08
Top 10 Biotech IPOs on NASDAQ in 2021
2022-01-19
Sex Dimorphism in Obesity and the Impact of Estrogen Hormone Therapy on Cardiometabolic Health
2022-01-17
Recent Advances in Breast Cancer Treatments: An Overview
2022-01-15
GeneOnline’s Top 10 Hong Kong Biotech IPOs of 2021
2022-01-07
GeneOnline’s Pick: Notable Novel FDA Approved Drugs in 2021
2022-01-05
A New Study Reveals Viagra Could Decrease the Risk of Alzheimer’s Disease
2021-12-08
BeiGene launches IPO on Shanghai’s STAR market to raise $3B
2021-12-03
Brukinsa Receives EU Approval for the Treatment of Rare Lymphoma
2021-11-27
Cancer Cells Build Nano-Highways to Hijack Mitochondria from Immune Cells
2021-11-25
1 2 3 4 11
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top